{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:31:53Z","timestamp":1787963513581,"version":"build-2784847793"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Addis Ababa University Swedish International Development cooperation agency project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10359-3","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T14:20:46Z","timestamp":1735395646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial resistance profile, biofilm forming capacity and associated factors of multidrug resistance in Pseudomonas aeruginosa among patients admitted at Tikur Anbessa Specialized Hospital and Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"24","author":[{"given":"Matifan Dereje","family":"Olana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Asrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6te","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"issue":"1","key":"10359_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1099\/mic.0.000860","volume":"166","author":"SP Diggle","year":"2020","unstructured":"Diggle SP, Whiteley M. Microbe profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbioly(Reading). 2020;166(1):30\u20133. https:\/\/doi.org\/10.1099\/mic.0.000860.","journal-title":"Microbioly(Reading)"},{"issue":"2","key":"10359_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","volume":"6","author":"P Pachori","year":"2019","unstructured":"Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 2019;6(2):109\u201319. https:\/\/doi.org\/10.1016\/j.gendis.2019.04.001.","journal-title":"Genes Dis"},{"issue":"1","key":"10359_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/22221751.2022.2030196","volume":"11","author":"O Ayobami","year":"2022","unstructured":"Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022;11(1):443\u201351. https:\/\/doi.org\/10.1080\/22221751.2022.2030196.","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"10359_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10359_CR5","doi-asserted-by":"publisher","first-page":"e0021321","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. J Clin Microbiol. 2021;59(12):e0021321. https:\/\/doi.org\/10.1128\/JCM.00213-21.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10359_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177\u201392. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.11.013.","journal-title":"Biotechnol Adv"},{"key":"10359_CR7","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution. Drug Resist Updat. 2019;44:100640. https:\/\/doi.org\/10.1016\/j.drup.2019.07.002.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"10359_CR8","doi-asserted-by":"publisher","first-page":"e0308946","DOI":"10.1371\/journal.pone.0308946","volume":"19","author":"Z Asmare","year":"2024","unstructured":"Asmare Z, Reta MA, Gashaw Y, Getachew E, Sisay A, Gashaw M, Tamrat E, Kidie AA, Abebe W, Misganaw T, Ashagre A, Dejazmach Z, Kumie G, Nigatie M, Ayana S, Jemal A, Gedfie S, Kassahun W, Kassa MA, Tadesse S, Abate BB. Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: a systematic review and meta-analysis. PLoS ONE. 2024;19(8):e0308946. https:\/\/doi.org\/10.1371\/journal.pone.0308946.","journal-title":"PLoS ONE"},{"key":"10359_CR9","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.2147\/IDR.S327652","volume":"14","author":"T Addis","year":"2021","unstructured":"Addis T, Araya S, Desta K. Occurrence of multiple, extensive and Pan Drug-Resistant Pseudomonas aeruginosa and Carbapenemase Production from Presumptive isolates stored in a Biobank at Ethiopian Public Health Institute. Infect Drug Resist. 2021;14:3609\u201318. https:\/\/doi.org\/10.2147\/IDR.S327652.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10359_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/biomedicines11041221","volume":"11","author":"C Verdial","year":"2023","unstructured":"Verdial C, Serrano I, Tavares L, Gil S, Oliveira M. Mechanisms of antibiotic and Biocide Resistance that Contribute to Pseudomonas aeruginosa Persistence in the Hospital Environment. Biomedicines. 2023;11(4):1221. https:\/\/doi.org\/10.3390\/biomedicines11041221.","journal-title":"Biomedicines"},{"issue":"22","key":"10359_CR11","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","volume":"21","author":"MTT Thi","year":"2020","unstructured":"Thi MTT, Wibowo D, Rehm BHA. Pseudomonas aeruginosa Biofilms. Int J Mol Sci. 2020;21(22):8671. https:\/\/doi.org\/10.3390\/ijms21228671.","journal-title":"Int J Mol Sci"},{"issue":"Ci","key":"10359_CR12","first-page":"9","volume":"1","author":"L Naing","year":"2006","unstructured":"Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for Prevalence studies. Arch Orofac Sci. 2006;1(Ci):9\u201314. https:\/\/api.semanticscholar.org\/CorpusID:961076.","journal-title":"Arch Orofac Sci"},{"key":"10359_CR13","unstructured":"Monica Cheesbrough 1. District Laboratory Practice in Tropical Countries: Part 1 Second Edition. Cambridge University Press. 2005. 1\u2013462 p. ISBN 0521676304, 9780521676304."},{"issue":"2","key":"10359_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cmi.2019.10.006","volume":"26","author":"S Huber","year":"2020","unstructured":"Huber S, Hetzer B, Crazzolara R, Orth-H\u00f6ller D. The correct blood volume for paediatric blood cultures: a conundrum? Clin Microbiol Infect. 2020;26(2):168\u201373. https:\/\/doi.org\/10.1016\/j.cmi.2019.10.006.","journal-title":"Clin Microbiol Infect"},{"key":"10359_CR15","doi-asserted-by":"publisher","unstructured":"Bonham PA. Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Cont Nurs. 2009 Jul-Aug;36(4):389\u201395. https:\/\/doi.org\/10.1097\/WON.0b013e3181aaef7f.","DOI":"10.1097\/WON.0b013e3181aaef7f"},{"issue":"10","key":"10359_CR16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/diagnostics10100832","volume":"10","author":"N Karah","year":"2020","unstructured":"Karah N, Rafei R, Elamin W, Ghazy A, Abbara A, Hamze M, et al. Guideline for urine culture and biochemical identification of bacterial urinary pathogens in low-resource settings. Diagnostics (Basel). 2020;10(10):832. https:\/\/doi.org\/10.3390\/diagnostics10100832.","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10359_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10359_CR18","doi-asserted-by":"publisher","first-page":"17316","DOI":"10.1016\/j.sjbs.2018.07.009","volume":"26","author":"P Karami","year":"2019","unstructured":"Karami P, Mohajeri P, Yousefi Mashouf R, Karami M, Yaghoobi MH, Dastan D, et al. Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center. Saudi J Biol Sci. 2019;26(7):17316. https:\/\/doi.org\/10.1016\/j.sjbs.2018.07.009.","journal-title":"Saudi J Biol Sci"},{"key":"10359_CR19","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.2147\/IDR.S328781","volume":"14","author":"F Yang","year":"2021","unstructured":"Yang F, Liu C, Ji J, Cao W, Ding B, Xu X, Molecular Characteristics. Antimicrobial Resistance, and Biofilm formation of Pseudomonas aeruginosa isolated from patients with aural infections in Shanghai, China. Infect Drug Resist. 2021;14:3637\u201345. https:\/\/doi.org\/10.2147\/IDR.S328781.","journal-title":"Infect Drug Resist"},{"issue":"18","key":"10359_CR20","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M. The epidemiology and Pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs. 2021;81(18):2117\u201331. https:\/\/doi.org\/10.1007\/s40265-021-01635-6.","journal-title":"Drugs"},{"issue":"suppl1","key":"10359_CR21","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/infdis\/jiw299","volume":"215","author":"C Juan","year":"2017","unstructured":"Juan C, Pe\u00f1a C, Oliver A. Host and Pathogen biomarkers for severe Pseudomonas aeruginosa infections. J Infect Dis. 2017;215(suppl1):S44\u201351. https:\/\/doi.org\/10.1093\/infdis\/jiw299.","journal-title":"J Infect Dis"},{"key":"10359_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.174","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Infect Control Hosp Epidemiol. 2016;37(11):1288\u2013301. https:\/\/doi.org\/10.1017\/ice.2016.174. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014."},{"issue":"5","key":"10359_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/1120009X.2020.1823679","volume":"33","author":"MM Folic","year":"2021","unstructured":"Folic MM, Djordjevic Z, Folic N, Radojevic MZ, Jankovic SM. Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa. J Chemother. 2021;33(5):294\u2013301. https:\/\/doi.org\/10.1080\/1120009X.2020.1823679.","journal-title":"J Chemother"},{"key":"10359_CR24","doi-asserted-by":"publisher","unstructured":"Matos ECO, Andriolo RB, Rodrigues YC, Lima PDL, Carneiro ICDRS, Lima KVB. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis. Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):415\u201320. https:\/\/doi.org\/10.1590\/0037-8682-0506-2017.","DOI":"10.1590\/0037-8682-0506-2017"},{"key":"10359_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jgar.2022.06.026","volume":"30","author":"M Rolo","year":"2022","unstructured":"Rolo M, Mart\u00edn-Higuera MC, Viedma E, Villa J, Manche\u00f1o-Losa M, Lora-Tamayo J, et al. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia. J Glob Antimicrob Resist. 2022;30:269\u201375. https:\/\/doi.org\/10.1016\/j.jgar.2022.06.026.","journal-title":"J Glob Antimicrob Resist"},{"key":"10359_CR26","doi-asserted-by":"publisher","first-page":"1294141","DOI":"10.3389\/fpubh.2023.1294141","volume":"11","author":"S Xiao","year":"2024","unstructured":"Xiao S, Liang X, Han L, Zhao S. Incidence, antimicrobial resistance and mortality of Pseudomonas aeruginosa bloodstream infections among hospitalized patients in China: a retrospective observational multicenter cohort study from 2017 to 2021. Front Public Health. 2024;11:1294141. https:\/\/doi.org\/10.3389\/fpubh.2023.1294141.","journal-title":"Front Public Health"},{"issue":"3","key":"10359_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4314\/ejhs.v33i3.5","volume":"33","author":"T Asamenew","year":"2023","unstructured":"Asamenew T, Worku S, Motbainor H, Mekonnen D, Deribe A. Antimicrobial Resistance Profile of Pseudomonas aeruginosa from different clinical samples in Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2023;33(3):423\u201332. https:\/\/doi.org\/10.4314\/ejhs.v33i3.5.","journal-title":"Ethiop J Health Sci"},{"issue":"1","key":"10359_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/07853890.2021.1900594","volume":"53","author":"R Wang","year":"2021","unstructured":"Wang R, Ding S, Lei C, Yang D, Luo H. The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study. Ann Med. 2021;53(1):459\u201369. https:\/\/doi.org\/10.1080\/07853890.2021.1900594.","journal-title":"Ann Med"},{"issue":"4","key":"10359_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.29271\/jcpsp.2018.04.279","volume":"28","author":"M Saeed","year":"2018","unstructured":"Saeed M, Rasheed F, Afzal RK, Hussain S, Riaz S, Ahmad A. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-ResistrendsTrends in a Tertiary Care Hospital. J Coll Physicians Surg Pak. 2018;28(4):279\u201383. https:\/\/doi.org\/10.29271\/jcpsp.2018.04.279.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"3","key":"10359_CR30","doi-asserted-by":"publisher","first-page":"e0289586","DOI":"10.1371\/journal.pone.0289586","volume":"19","author":"FA Abdi","year":"2024","unstructured":"Abdi FA, Motumma AN, Kalayu AA, Abegaz WE. Prevalence and antimicrobial-resistant patterns of Pseudomonas aeruginosa among burn patients attending Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia. PLoS ONE. 2024;19(3):e0289586. https:\/\/doi.org\/10.1371\/journal.pone.0289586.","journal-title":"PLoS ONE"},{"key":"10359_CR31","doi-asserted-by":"publisher","unstructured":"Migliara G, Di Paolo C, Barbato D, Baccolini V, Salerno C, Nardi A et al. Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital. Ann Ig 2019 Sep-Oct;31(5):399\u2013413. https:\/\/doi.org\/10.7416\/ai.2019.2302","DOI":"10.7416\/ai.2019.2302"},{"key":"10359_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s13104-015-1497-x","volume":"8","author":"T Bekele","year":"2015","unstructured":"Bekele T, Tesfaye A, Sewunet T, Waktola HD. Pseudomonas aeruginosa isolates and their antimicrobial susceptibility pattern among catheterized patients at Jimma University Teaching Hospital, Jimma, Ethiopia. BMC Res Notes. 2015;8:488. https:\/\/doi.org\/10.1186\/s13104-015-1497-x.","journal-title":"BMC Res Notes"},{"issue":"4","key":"10359_CR33","doi-asserted-by":"publisher","first-page":"e068359","DOI":"10.1136\/bmjopen-2022-068359","volume":"13","author":"A Shangali","year":"2023","unstructured":"Shangali A, Kamori D, Massawe W, Masoud S, Kibwana U, Mwingwa AG, et al. Aetiology of ear infection and antimicrobial susceptibility pattern among patients attending otorhinolaryngology clinic at a tertiary hospital in Dar Es Salaam, Tanzania: a hospital-based cross-sectional study. BMJ Open. 2023;13(4):e068359. https:\/\/doi.org\/10.1136\/bmjopen-2022-068359.","journal-title":"BMJ Open"},{"key":"10359_CR34","doi-asserted-by":"publisher","unstructured":"Farhan SM, Ibrahim RA, Mahran KM, Hetta HF, El-Baky RMA. A Antimicrobial resistance pattern and molecular genetic distribution of metallo-\u03b2-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt. Infect Drug Resist. 2019;12:2125\u20132133. https:\/\/doi.org\/10.2147\/IDR.S198373","DOI":"10.2147\/IDR.S198373"},{"key":"10359_CR35","doi-asserted-by":"publisher","unstructured":"Yang X, Lai Y, Li C, Yang J, Jia M, Sheng J. Molecular epidemiology of Pseudomonas aeruginosa isolated from lower respiratory tract of ICU patients. Braz J Biol 2021 Mar-May;81(2):351\u201360. https:\/\/doi.org\/10.1590\/1519-6984.226309","DOI":"10.1590\/1519-6984.226309"},{"issue":"2","key":"10359_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcf.2008.11.001","volume":"8","author":"PK Knudsen","year":"2009","unstructured":"Knudsen PK, Olesen HV, H\u00f8iby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF, Study Consortium (SCFSC). Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros. 2009;8(2):135\u201342. https:\/\/doi.org\/10.1016\/j.jcf.2008.11.001.","journal-title":"J Cyst Fibros"},{"issue":"March","key":"10359_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.823684","volume":"12","author":"SS Jean","year":"2022","unstructured":"Jean SS, Harnod D, Hsueh PR. Global threat of Carbapenem-Resistant Gram-negative Bacteria. Front Cell Infect Microbiol. 2022;12(March):1\u201319. https:\/\/doi.org\/10.3389\/fcimb.2022.823684.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10359_CR38","doi-asserted-by":"publisher","first-page":"e0257272","DOI":"10.1371\/journal.pone.0257272","volume":"16","author":"H Mekonnen","year":"2021","unstructured":"Mekonnen H, Seid A, Fenta GM, Gebrecherkos T. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized hospital, NorthEast Ethiopia. A cross-sectional study. PLoS ONE. 2021;16(11):e0257272. https:\/\/doi.org\/10.1371\/journal.pone.0257272.","journal-title":"PLoS ONE"},{"key":"10359_CR39","doi-asserted-by":"publisher","unstructured":"Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2020;20(1):92. https:\/\/doi.org\/10.1186\/s12879-020-4811-8","DOI":"10.1186\/s12879-020-4811-8"},{"issue":"1","key":"10359_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.burns.2016.07.002","volume":"43","author":"K de Almeida Silva","year":"2017","unstructured":"de Almeida Silva K, de CF, Calomino MA, Deutsch G, de Castilho SR, de Paula GR, Esper LMR, et al. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center. Burns. 2017;43(1):137\u201343. https:\/\/doi.org\/10.1016\/j.burns.2016.07.002.","journal-title":"Burns"},{"issue":"1","key":"10359_CR41","doi-asserted-by":"publisher","first-page":"18402","DOI":"10.1038\/s41598-023-45417-4","volume":"13","author":"RF Polse","year":"2023","unstructured":"Polse RF, Khalid HM, Mero WMS. Distribution of blaOXA-10, blaPER-1, and blaSHV genes in ESBL-producing Pseudomonas aeruginosa strains isolated from burn patients. Sci Rep. 2023;13(1):18402. https:\/\/doi.org\/10.1038\/s41598-023-45417-4.","journal-title":"Sci Rep"},{"issue":"6","key":"10359_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/pathogens9060471","volume":"9","author":"RM Kishk","year":"2020","unstructured":"Kishk RM, Abdalla MO, Hashish AA, Nemr NA, El Nahhas N, Alkahtani S, et al. Efflux MexAB-Mediated resistance in P. Aeruginosa isolated from patients with Healthcare Associated Infections. Pathogens. 2020;9(6):471. https:\/\/doi.org\/10.3390\/pathogens9060471.","journal-title":"Pathogens"},{"issue":"5","key":"10359_CR43","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/jac\/dkz030","volume":"74","author":"A P\u00e9rez","year":"2019","unstructured":"P\u00e9rez A, Gato E, P\u00e9rez-Llarena J, Fern\u00e1ndez-Cuenca F, Gude MJ, Ovia\u00f1o M, Pach\u00f3n ME, Garnacho J, Gonz\u00e1lez V, Pascual \u00c1, Cisneros JM, Bou G. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2019;74(5):1244\u201352. https:\/\/doi.org\/10.1093\/jac\/dkz030.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10359_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13104-020-05224-w","volume":"13","author":"B Mirzaei","year":"2020","unstructured":"Mirzaei B, Bazgir ZN, Goli HR, Iranpour F, Mohammadi F, Babaei R. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran. BMC Res Notes. 2020;13(1):4\u20139. https:\/\/doi.org\/10.1186\/s13104-020-05224-w.","journal-title":"BMC Res Notes"},{"key":"10359_CR45","doi-asserted-by":"publisher","first-page":"9976064","DOI":"10.1155\/2021\/9976064","volume":"2021","author":"H Odoi","year":"2021","unstructured":"Odoi H, Boamah VE, Boakye YD, Agyare C. Prevalence and phenotypic and genotypic resistance mechanisms of Multidrug-Resistant Pseudomonas aeruginosa strains isolated from clinical, environmental, and Poultry Litter Samples from the Ashanti Region of Ghana. J Environ Public Health. 2021;2021:9976064. https:\/\/doi.org\/10.1155\/2021\/9976064.","journal-title":"J Environ Public Health"},{"key":"10359_CR46","doi-asserted-by":"publisher","first-page":"835403","DOI":"10.3389\/fmicb.2022.835403","volume":"13","author":"S Kiyaga","year":"2022","unstructured":"Kiyaga S, Kyany\u2019a C, Muraya AW, Smith HJ, Mills EG, Kibet C, et al. Genetic diversity, distribution, and genomic characterization of Antibiotic Resistance and Virulence of Clinical Pseudomonas aeruginosa strains in Kenya. Front Microbiol. 2022;13:835403. https:\/\/doi.org\/10.3389\/fmicb.2022.835403.","journal-title":"Front Microbiol"},{"key":"10359_CR47","doi-asserted-by":"publisher","first-page":"157975","DOI":"10.1016\/j.scitotenv.2022.157975","volume":"850","author":"P Dawadi","year":"2022","unstructured":"Dawadi P, Khadka C, Shyaula M, Syangtan G, Joshi TP, Pepper SH, Kanel SR, Pokhrel LR. Prevalence of metallo-\u03b2-lactamases as a correlate of multidrug resistance among clinical Pseudomonas aeruginosa isolates in Nepal. Sci Total Environ. 2022;850:157975. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.157975.","journal-title":"Sci Total Environ"},{"issue":"3","key":"10359_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.14715\/cmb\/2021.67.3.7","volume":"67","author":"FA Ali","year":"2021","unstructured":"Ali FA, Bakir SH, Haji SH, Hussen BM. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates. Cell Mol Biol (Noisy-le-grand). 2021;67(3):52\u201360. https:\/\/doi.org\/10.14715\/cmb\/2021.67.3.7.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"8","key":"10359_CR49","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s10096-019-03585-0","volume":"38","author":"A De Rosa","year":"2019","unstructured":"De Rosa A, Mutters NT, Mastroianni CM, Kaiser SJ, G\u00fcnther F. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2019;38(8):1547\u201352. https:\/\/doi.org\/10.1007\/s10096-019-03585-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10359_CR50","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.2147\/IDR.S358778","volume":"15","author":"J Qin","year":"2022","unstructured":"Qin J, Zou C, Tao J, Wei T, Yan L, Zhang Y, Wang H. Carbapenem Resistant Pseudomonas aeruginosa infections in Elderly patients: Antimicrobial Resistance profiles, risk factors and impact on clinical outcomes. Infect Drug Resist. 2022;15:2301\u201314. https:\/\/doi.org\/10.2147\/IDR.S358778.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10359_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.26574\/maedica.2022.17.1.134","volume":"17","author":"A Radhika","year":"2022","unstructured":"Radhika A, Lakshmi JT, Ariyanachi K, Sakthivadivel V. Detection of Metallo Beta-Lactamase (MBL) producing Pseudomonas aeruginosa in a Tertiary Care Hospital, Ghanpur, Medchal, India. Maedica (Bucur). 2022;17(1):134\u201342. https:\/\/doi.org\/10.26574\/maedica.2022.17.1.134.","journal-title":"Maedica (Bucur)"},{"issue":"1","key":"10359_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s12879-019-4510-5","volume":"19","author":"D Aruhomukama","year":"2019","unstructured":"Aruhomukama D, Najjuka CF, Kajumbula H, Okee M, Mboowa G, Sserwadda I, et al. blaVIM- and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda. BMC Infect Dis. 2019;19(1):853. https:\/\/doi.org\/10.1186\/s12879-019-4510-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10359_CR53","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1186\/s40064-016-2986-7","volume":"5","author":"DP Kateete","year":"2016","unstructured":"Kateete DP, Nakanjako R, Namugenyi J, Erume J, Joloba ML, Najjuka CF. Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007\u20132009). Springerplus. 2016;5(1):1308. https:\/\/doi.org\/10.1186\/s40064-016-2986-7.","journal-title":"Springerplus"},{"issue":"4","key":"10359_CR54","first-page":"332","volume":"17","author":"H Fazeli","year":"2012","unstructured":"Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel\u2019s specimens. J Res Med Sci. 2012;17(4):332\u20137. PMID: 23267393.","journal-title":"J Res Med Sci"},{"issue":"7","key":"10359_CR55","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/jac\/dkz147","volume":"74","author":"E Del Barrio-Tofin\u00f5","year":"2019","unstructured":"Del Barrio-Tofin\u00f5 E, Zamorano L, Cortes-Lara S, L\u00f3pez-Causape C, S\u00e1nchez-Diener I, Cabot G, et al. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology. J Antimicrob Chemother. 2019;74(7):1825\u201335. https:\/\/doi.org\/10.1093\/jac\/dkz147.","journal-title":"J Antimicrob Chemother"},{"key":"10359_CR56","doi-asserted-by":"publisher","unstructured":"Gill JS, Arora S, Khanna SP, Kumar KH. Prevalence of Multidrug-resistant, extensively Drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a Tertiary Level Intensive Care Unit. J Glob Infect Dis 2016 Oct-Dec;8(4):155\u20139. https:\/\/doi.org\/10.4103\/0974-777X.192962","DOI":"10.4103\/0974-777X.192962"},{"issue":"5","key":"10359_CR57","doi-asserted-by":"publisher","first-page":"DC26","DOI":"10.7860\/JCDR\/2014\/7483.4383","volume":"8","author":"I Biswal","year":"2014","unstructured":"Biswal I, Arora BS, Kasana D, Neetushree. Incidence of multidrug resistant Pseudomonas aeruginosa isolated from burn patients and environment of teaching institution. J Clin Diagn Res. 2014;8(5):DC26\u20139. https:\/\/doi.org\/10.7860\/JCDR\/2014\/7483.4383.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10359_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-12471-3","volume":"12","author":"N Kumar","year":"2022","unstructured":"Kumar N, Katiyar M, Kumar A, Priya A, Kumar P. Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India. Sci Rep. 2022;12(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-022-12471-3.","journal-title":"Sci Rep"},{"issue":"1","key":"10359_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1517\/14656566.9.1.23","volume":"9","author":"DP Nicolau","year":"2008","unstructured":"Nicolau DP. Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother. 2008;9(1):23\u201337. https:\/\/doi.org\/10.1517\/14656566.9.1.23.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10359_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2478\/jvetres-2019-0049","volume":"63","author":"EA Elshafiee","year":"2019","unstructured":"Elshafiee EA, Nader SM, Dorgham SM, Hamza DA. Carbapenem-resistant Pseudomonas Aeruginosa originating from Farm animals and people in Egypt. J Vet Res. 2019;63(3):333\u20137. https:\/\/doi.org\/10.2478\/jvetres-2019-0049.","journal-title":"J Vet Res"},{"issue":"12 December","key":"10359_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0256556","volume":"16","author":"A Abdeta","year":"2021","unstructured":"Abdeta A, Bitew A, Fentaw S, Tsige E, Assefa D, Lejisa T, et al. Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens. PLoS ONE. 2021;16(12 December):1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0256556.","journal-title":"PLoS ONE"},{"issue":"2","key":"10359_CR62","doi-asserted-by":"publisher","first-page":"306","DOI":"10.26444\/aaem\/122682","volume":"28","author":"M Ratajczak","year":"2021","unstructured":"Ratajczak M, Kami\u0144ska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinical strains. Ann Agric Environ Med. 2021;28(2):306\u201313. https:\/\/doi.org\/10.26444\/aaem\/122682.","journal-title":"Ann Agric Environ Med"},{"issue":"April","key":"10359_CR63","doi-asserted-by":"publisher","first-page":"104989","DOI":"10.1016\/j.micpath.2021.104989","volume":"157","author":"L Yamani","year":"2021","unstructured":"Yamani L, Alamri A, Alsultan A, Alfifi S, Ansari MA, Alnimr A. Inverse correlation between biofilm production efficiency and antimicrobial resistance in clinical isolates of Pseudomonas aeruginosa. Microb Pathog. 2021;157(April):104989. https:\/\/doi.org\/10.1016\/j.micpath.2021.104989.","journal-title":"Microb Pathog"},{"key":"10359_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.micpath.2017.05.004","volume":"109","author":"S Gholami","year":"2017","unstructured":"Gholami S, Tabatabaei M, Sohrabi N. Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates. Microb Pathog. 2017;109:94\u20138. https:\/\/doi.org\/10.1016\/j.micpath.2017.05.004.","journal-title":"Microb Pathog"},{"issue":"4","key":"10359_CR65","doi-asserted-by":"publisher","first-page":"e02431","DOI":"10.1128\/AAC.02431-18","volume":"63","author":"D Yin","year":"2019","unstructured":"Yin D, Wu S, Yang Y, Shi Q, Dong D, Zhu D, et al. China Antimicrobial Surveillance Network (CHINET) Study Group. Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the in vitro activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2019;63(4):e02431\u201318. https:\/\/doi.org\/10.1128\/AAC.02431-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10359_CR66","doi-asserted-by":"publisher","first-page":"e0169722","DOI":"10.1128\/spectrum.01697-22","volume":"10","author":"C Weber","year":"2022","unstructured":"Weber C, Schultze T, G\u00f6ttig S, Kessel J, Schr\u00f6der A, Tietgen M, Besier S, Burbach T, H\u00e4ussler S, Wichelhaus TA, Hack D, Kempf VAJ, Hogardt M. Antimicrobial activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa recovered at a German University Hospital. Microbiol Spectr. 2022;10(5):e0169722. https:\/\/doi.org\/10.1128\/spectrum.01697-22.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10359_CR67","first-page":"363","volume":"48","author":"HH Cho","year":"2018","unstructured":"Cho HH, Kwon KC, Kim S, Park Y, Koo SH. Association between biofilm formation and antimicrobial resistance in carbapenem-resistant Pseudomonas aeruginosa. Ann Clin Lab Sci. 2018;48(3):363\u20138. PMID: 29970441.","journal-title":"Ann Clin Lab Sci"},{"key":"10359_CR68","doi-asserted-by":"publisher","unstructured":"Diriba K, Kassa T, Alemu Y, Bekele S. In Vitro Biofilm formation and antibiotic susceptibility patterns of Bacteria from suspected External Eye Infected patients attending Ophthalmology Clinic, Southwest Ethiopia. Int J Microbiol. 2020;2020(8472395). https:\/\/doi.org\/10.1155\/2020\/8472395.","DOI":"10.1155\/2020\/8472395"},{"issue":"11","key":"10359_CR69","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/antibiotics","volume":"11","author":"P Hern\u00e1ndez-Jim\u00e9nez","year":"2022","unstructured":"Hern\u00e1ndez-Jim\u00e9nez P, L\u00f3pez-Medrano F, Fern\u00e1ndez-Ruiz M, Silva JT, Corbella L, San Juan R, et al. Risk factors and outcomes for Multidrug Resistant Pseudomonas aeruginosa infection in immunocompromised patients. Antibiot (Basel). 2022;11(11):1459. https:\/\/doi.org\/10.3390\/antibiotics.","journal-title":"Antibiot (Basel)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10359-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T15:02:00Z","timestamp":1735398120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10359-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10359-3","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research project was ethically approved by the Department Research Ethics Review Committee (DRERC) of Microbiology, Immunology and Parasitology and Institutional Review Board (IRB) (Protocol number: 054\/22DMIP) of College of Health Sciences of Addis Ababa University and then by National Ethics Review Committee (NERC) (ref no: 17\/152\/845\/23). Before being recruited for the study, the purposes of study were explained to participants or participants\u2019 parents or guardians. The children whose parents or guardians provided informed consent as well as the study participants who provided written informed consent were included to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1472"}}